Likewise, the expression levels of Th-1 signature genes were the most highly increased in group IV* compared with the other subgroups, and a similar co-expression pattern of cytotoxic molecules was also observed across the colon cancer risk subgroups (Figure 7). The gene discussed is NELFCD; the disease is malignant colon neoplasm.